Sector dosimetric analysis of sagittal vs axial ultrasound guided source placement in I-125 prostate brachytherapy

被引：0
|
作者：
Yoosuf, A. B. Mohamed [1 ]
Mitchell, D. M. [2 ]
Byrne, M. [1 ]
Flynn, M. [1 ]
Napier, E. [2 ]
Jain, S. [2 ]
Workman, G. [1 ]
机构：
[1] Northern Ireland Canc Ctr, Radiotherapy Med Phys Sect, Belfast, Antrim, North Ireland
[2] Northern Ireland Canc Ctr, Clin Oncol, Belfast, Antrim, North Ireland
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1030
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [41] Dosimetric Comparison of Cs-131 Vs. I-125 Vs. Pd-103 Intraoperative Brachytherapy in Patients with Resected Brain Metastasis
    Nedialkova, L.
    Sabbas, A.
    Trichter, S.
    Kulidzhanov, F.
    Delamerced, M.
    Parashar, B.
    Nori
    Chao, K.
    Yondorf, M.
    Wernicke, G.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [42] Application of Hybrid Source in Slotted Plaque Brachytherapy for the Treatment of Uveal Melanoma and Dosimetric Comparison of Plans with I-125 and Pd-103 Sources
    Awan, S.
    Meigooni, A.
    Howard, S.
    Tejwani, A.
    Badkul, R.
    Saleh, H.
    MEDICAL PHYSICS, 2019, 46 (06) : E579 - E579
  • [43] Technical note: Check software for use with trans-rectal ultrasound guided I-125 seed prostate implants
    Kermode, RH
    Locks, SM
    MEDICAL PHYSICS, 2001, 28 (07) : 1406 - 1409
  • [44] Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy
    Chen, CT
    Waterman, FM
    Valicenti, RK
    Gomella, LG
    Strup, SE
    Dicker, AP
    INTERNATIONAL JOURNAL OF CANCER, 2001, 96 : 83 - 88
  • [45] Analysis of seed loss at day of implant for I-125 prostate brachytherapy. Can we skip the CT scan?
    Schokker, R.
    Bazen, W. A.
    van Zijp, J. R. N. Van der Voort
    Moerland, M. A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S190 - S190
  • [46] A prospective analysis of tong-term quality of life after permanent I-125 brachytherapy for locatised prostate cancer
    Ash, Dan
    Bottomley, David
    Al-Qaisieh, Bashar
    Carey, Brendan
    Gould, Kath
    Henry, Ann
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 (02) : 135 - 139
  • [47] Analysis of Incidence and Risk Factor of Seed Migration After Transperineal Interstitial Prostate Brachytherapy with I-125 Free Seeds
    Miyazawa, K.
    Nakai, D.
    Morita, N.
    Chikazawa, I
    Suga, K.
    Moriyama, M.
    Tanaka, T.
    Suzuki, K.
    Matoba, M.
    Minato, H.
    UROLOGY, 2012, 80 (03) : S290 - S290
  • [48] Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors
    Katsuhito Miyazawa
    Munetaka Matoba
    Hiroshi Minato
    Nobuyo Morita
    Ippei Chikazawa
    Kiyotaka Ota
    Kosuke Tokunaga
    Hisao Tonami
    Takayuki Nojima
    Koji Suzuki
    Japanese Journal of Radiology, 2012, 30 : 635 - 641
  • [49] Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors
    Miyazawa, Katsuhito
    Matoba, Munetaka
    Minato, Hiroshi
    Morita, Nobuyo
    Chikazawa, Ippei
    Ota, Kiyotaka
    Tokunaga, Kosuke
    Tonami, Hisao
    Nojima, Takayuki
    Suzuki, Koji
    JAPANESE JOURNAL OF RADIOLOGY, 2012, 30 (08) : 635 - 641
  • [50] Dosimetric and volumetric criteria for selecting a source activity and a source type (125I or 103Pd) in the presence of irregular seed placement in permanent prostate implants
    Wuu, CS
    Ennis, RD
    Schiff, PB
    Lee, EK
    Zaider, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (03): : 815 - 820
12345